Personalis (STU:04X) YoY EBITDA Growth : 64.34% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Personalis YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Personalis's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 64.34%.

Personalis's EBITDA per Share for the three months ended in Mar. 2024 was €-0.18.

Personalis YoY EBITDA Growth Historical Data

The historical data trend for Personalis's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Personalis YoY EBITDA Growth Chart

Personalis Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-59.04

11.57

-40.33

-81.60

14.72

Personalis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															3.01	23.50	6.30	23.43	64.34

Personalis YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Personalis's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-1.843	-	-2.161)	/	\| -2.161 \|
=	14.72 %

Personalis's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.184	-	-0.516)	/	\| -0.516 \|
=	64.34 %

Personalis YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Personalis's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Personalis (STU:04X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Personalis Inc (STU:04X) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

PSNL:USA

Address

6600 Dumbarton Circle, Fremont, CA, USA, 94555

Website

https://www.personalis.com

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions.

Personalis (STU:04X) Headlines

No Headlines